You are here

TRIUMF and CNL announce MOU to collaborate on nuclear science and technology

24 January 2023

TRIUMF is pleased to announce a new agreement with Canadian Nuclear Laboratories (CNL) to explore and pursue collaborative opportunities in nuclear and materials science and technology.

The memorandum of understanding (MOU) is intended to foster closer ties between two of Canada’s leading nuclear research organizations, leverage their complementary capabilities, and identify areas of cooperation that include the delivery of joint research projects and the sharing of scientific information and equipment.

The work will focus on topics that are of mutual interest to both organizations, including health sciences; materials sciences and radiation; analytical and imaging technologies; the processing and management of highly radioactive components; cyber security; and accelerator, particle detection, and reactor technologies. This agreement is an opportunity to accelerate key areas of research and innovation, better utilize CNL and TRIUMF’s respective resources to accomplish shared goals, and continue leveraging national science infrastructure for the benefit of Canadians.

“This agreement bolsters the long-standing relationship between TRIUMF and CNL, and opens new and exciting opportunities for synergy in the Canadian nuclear science landscape,” said TRIUMF Director Dr. Nigel Smith. “This will serve to enhance Canada’s global science leadership on a number of fronts, from making advances in accelerator science and nuclear research to training the next generation of scientific leaders and fortifying Canada’s strategic advantage in the development and production of critical life-saving medical isotopes.”

Read the full press release here: